This marks an important milestone for Adexilis as we continue to expand our presence and strengthen our commitment to delivering innovative, high-quality solutions across the region. With our new entity in Serbia, we are bringing...Read More
Zurich, Switzerland –July 24, 2025, – Adexilis, a European pharmaceutical company that is providing access to innovative medicines in more than 20 Markets across the CEE Region, has announced a transformative distribution agreement with Bausch + Lomb,...Read More
ADEXILIS Bulgaria just opened its doors. Based out of Sofia, ADEXILIS Bulgaria will represent the Adexilis portfolio. With ADEXILIS Bulgaria we welcome great colleagues to the ADEXILIS family. We are excited to build further the...Read More
Adexilis is proud to announce that effective January 1, 2022 Adexilis Romania s.r.o. became promotional partner of Bausch Health in Romania. Dan Captaru, Managing Partner of Adexilis Romania: “We are very excited supporting Bausch Health...Read More
We are proud to announce that ADEXILIS will represent VSL#3 in our markets. Between May 2021 and August 2021 we will take over the representation from Ferring. With VSL#3 we will be strengthen our Gastroenterology...Read More
ADEXILIS ADRIA just opened its doors. Based out of Zagreb, Croatia ADEXILIS ADRIA will serve several markets, including Croatia, Serbia, Slovenia. Starting with several great products in Gastroenterology and true innovation in hormone free contraception....Read More
